Gastroesophageal reflux disease (GERD) is a highly prevalent, chronic gastrointestinal disorder. GERD that remains undiagnosed and/or undertreated can result in serious complications, including erosive esophagitis (EE), esophageal strictures, Barrett esophagus, and esophageal adenocarcinoma. In this live, interactive townhall, expert faculty will discuss the latest evidence regarding the diagnosis and management of GERD and EE, including new medical therapies. Faculty will use patient cases to contextualize clinical information that learners can apply in their own practices.
The goal of this activity is that learners will be better able to diagnose and treat EE and improve their understanding of how emerging treatment options may be incorporated into evidence-based care for their patients.
Upon completion of this activity, participants will: Have increased knowledge regarding the [LIST] [ITEM]Evidence-based recommendations for the diagnosis of EE [ITEM]Clinical data on treatments for proton pump inhibitor (PPI)-refractory EE[/LIST] Have greater competence related to [LIST] [ITEM]Determining gastroesophageal reflux disease (GERD) severity grade based on clinical criteria[/LIST]
[JALOGO] [MEDSCAPE] In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
[bold]For Physicians[/bold] Medscape, LLC designates this live activity for a maximum of 1.0 [italic][bold]AMA PRA Category 1 Credit(s)™[/bold][/italic]. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The Westin Charlotte
601 S College Street
Charlotte, North Carolina, 28202